The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Tumor Embolization Devices Market During 2026–2030?
The tumor embolization devices market has shown significant growth in recent years. Its value is projected to rise from $1587.48 billion in 2025 to $1732.02 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.1%. This historical expansion is credited to factors such as the proliferation of interventional oncology practices, an increased incidence of solid tumors, the greater embrace of minimally invasive procedures, the availability of advanced catheter technologies, and the broadening application of embolization within cancer care.
The tumor embolization devices market is anticipated to experience substantial expansion over the coming years. Its valuation is projected to reach $2464.52 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This projected growth during the forecast period is attributable to several factors, including escalating investments in interventional oncology, a heightened demand for combination cancer therapies, the broadening of targeted drug delivery techniques, an increasing emphasis on organ-sparing treatments, and the greater integration of imaging-guided interventions. Key trends anticipated during the forecast timeframe encompass the expanding adoption of targeted embolization therapies, an increasing requirement for drug-eluting embolic agents, the wider application of image-guided embolization procedures, the diversification of minimally invasive oncology interventions, and an intensified focus on precise tumor targeting.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp
What Underlying Factors Are Accelerating The Growth Of The Tumor Embolization Devices Market?
The global increase in cancer diagnoses is expected to fuel the expansion of the tumor embolization devices market throughout the forecast period. Cancer is characterized by the uncontrolled proliferation of abnormal cells that can infiltrate or metastasize to various bodily regions. This escalation in cancer cases is primarily attributed to aging demographics, given that older individuals face a greater predisposition to cancer owing to accumulated genetic alterations and extended exposure to causative elements. Tumor embolization devices address the growing number of cancer cases by offering a precise, minimally invasive therapeutic option that restricts blood supply to tumors, thereby inhibiting their progression and enhancing patient recovery. For example, the American Cancer Society Inc., a US-based non-profit health organization, reported 1,958,310 new cancer cases diagnosed in the US in 2023, representing an uptick from over 1,918,030 new cases recorded in 2022. Consequently, the escalating global cancer incidence rate is projected to significantly enhance the demand for the tumor embolization market in the coming years.
How Are The Various Segments Of The Tumor Embolization Devices Market Categorized?
The tumor embolization devices market covered in this report is segmented –
1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers
Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol – PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)
What Trends Are Affecting The Expansion Of The Tumor Embolization Devices Market?
Major companies in the tumor embolization devices market are increasingly focusing on introducing innovative medications, such as Eye90, to maximize their revenue in the sector. Eye90 microspheres represent a Y90 radioembolization device specifically engineered for treating liver tumors, particularly hepatocellular carcinoma. For instance, in May 2023, ABK Biomedical, a medical device company based in Canada, obtained Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to commence a multicenter pivotal study of Eye90 microspheres for hepatocellular carcinoma. Eye90 microspheres are a novel Y90 radioembolization technology created using a proprietary manufacturing process that yields microspheres with uniform size distribution and high radioactivity concentration. These microspheres are designed to deliver a significant radiation dose to the tumor while minimizing exposure to healthy tissue.
Which Major Firms Influence Developments In The Tumor Embolization Devices Market?
Major companies operating in the tumor embolization devices market are Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Kaneka Corporation, Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Surefire Medical Inc., Varian Medical Systems Inc.
Read the full tumor embolization devices market report here:
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Which Region Is Projected To Dominate The Tumor Embolization Devices Market During The Forecast Period?
North America was the largest region in the tumor embolization devices market in 2025. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Tumor Embolization Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3352&type=smp
Browse Through More Reports Similar to the Global Tumor Embolization Devices Market 2026, By The Business Research Company
Neurovascular Embolization Devices Market Report 2026
Transcatheter Embolization And Occlusion Devices Market Report 2026
Uterine Fibroid Embolization Device Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model